Duration of P2Y inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry)

Marwan Saad, Cardiovascular Institute, The Warren Alpert Medical School at Brown University, Providence, Rhode Island.
Jared Tobolski, Division of Cardiology, Maine Medical Center, Portland, Maine.
Dhaval Kolte, Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Yongfei Wang, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Karl Minges, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Ravi S. Hira, Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington.
Jeptha P. Curtis, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Jinnette Dawn Abbott, Cardiovascular Institute, The Warren Alpert Medical School at Brown University, Providence, Rhode Island. Electronic address: Jabbott@lifespan.org.

Abstract